prednisone has been researched along with Fetal Membranes, Premature Rupture in 3 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Fetal Membranes, Premature Rupture: Spontaneous tearing of the membranes surrounding the FETUS any time before the onset of OBSTETRIC LABOR. Preterm PROM is membrane rupture before 37 weeks of GESTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "8 mg per kilogram of body weight per day) and aspirin (100 mg per day) or placebo for the duration of the pregnancy." | 5.08 | Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. ( Bombardier, C; Farewell, V; Farine, D; Fielding, L; Hannah, ME; Laskin, CA; Mandel, FP; Ritchie, JW; Soloninka, CA; Spitzer, K; Yeung, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MartÃ-Gamboa, S | 1 |
| Savirón Cornudella, R | 1 |
| Campillos-Maza, JM | 1 |
| Laskin, CA | 1 |
| Bombardier, C | 1 |
| Hannah, ME | 1 |
| Mandel, FP | 1 |
| Ritchie, JW | 1 |
| Farewell, V | 1 |
| Farine, D | 1 |
| Spitzer, K | 1 |
| Fielding, L | 1 |
| Soloninka, CA | 1 |
| Yeung, M | 1 |
| Cowchock, FS | 1 |
| Reece, EA | 1 |
| Balaban, D | 1 |
| Branch, DW | 1 |
| Plouffe, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss[NCT04558268] | Phase 2/Phase 3 | 242 participants (Anticipated) | Interventional | 2020-12-31 | Not yet recruiting | ||
| Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)[NCT03152058] | Phase 2 | 55 participants (Anticipated) | Interventional | 2017-05-17 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisone and Fetal Membranes, Premature Rupture
| Article | Year |
|---|---|
[Massive gestational vulvar edema. A case report and review of literature].
Topics: Albumins; Anti-Infective Agents; Anticoagulants; Cesarean Section; Edema; Enoxaparin; Exudates and T | 2014 |
2 trials available for prednisone and Fetal Membranes, Premature Rupture
| Article | Year |
|---|---|
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Autoantibodies; Female; Fetal Membranes, Premature R | 1997 |
Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Female; Fetal Membranes, Premature Rupture; Heparin; | 1992 |